90% renewable electricity; on-site solar at new Ohio facility In 2024, Amgen sourced 90% renewable electricity across its facilities and achieved a 46% reduction in Scope 1+2 absolute carbon emissions (excluding offsets). The new Ohio fully-electric biomanufacturing facility includes an on-site solar array sized to generate 2,038 MWh annually and deliver renewable energy back to the local grid. Aim is for all Amgen facilities, wherever feasible, to procure 100% renewable energy by 2027.
▾ expand
Primary: Amgen Ecovation™ electrified biomanufacturing New facilities in North Carolina and Ohio were built using the Amgen Ecovation™ approach — flexible modular designs that are faster, lower-cost, and require less energy and water than traditional plants. The Ohio plant is Amgen's first fully electric biomanufacturing site, supporting the 2027 Scope 1+2 carbon neutrality goal.
▾ expand
TNFD alignment and biodiversity gap analysis Using initial gap analysis and ongoing alignment with TNFD framework to shape local mitigation and conservation strategies; identifying proximity of largest sites to biodiversity hotspots and legally protected areas.
▾ expand
High-quality Scope 1 carbon offsets augmenting efficiency portfolio In 2024, Amgen began augmenting its energy efficiency project portfolio with high-quality Scope 1 carbon emission offsets to assist progress toward its 2027 carbon neutrality ambition. Scope 1 emissions in 2024 include 40,000 MT of high-quality carbon offsets. The report frames these as offsets rather than durable removals.
▾ expand
Dependent: SBTi Scope 3 supplier engagement (73% by spend) On track to reach 2027 SBTi Scope 3 supplier target of engaging 73% of suppliers by spend in key categories to support their adoption of science-based targets. Science-based goal setting has also been embedded in Amgen's sourcing criteria.
▾ expand
Primary: Water and waste reduction projects In 2024 Amgen executed 198,000 CM of water saving projects and over 300 MT of waste reduction projects. Through 2024, achieved 57% of the 2027 40% water reduction target and 66% of the 75% waste reduction target vs a 2019 baseline.
▾ expand
2027 carbon neutrality (Scope 1+2) and SBTi Scope 3 supplier engagement target By 2027, achieve carbon neutrality for Amgen-owned and -operated facilities and operations; SBTi Scope 3 supplier engagement target to engage with 73% of suppliers by spend in key categories.
▾ expand
Carbon offsets included in Scope 1 In 2024, Scope 1 carbon emissions includes 40,000 MT of high-quality carbon offsets to assist progress toward carbon neutrality ambition.
▾ expand
TRUE Zero Waste Platinum at San Francisco R&D Achieved platinum-level TRUE Zero Waste Certification at San Francisco R&D facility, diverting more than 105 MT of waste from incineration and landfill.
▾ expand
First fully electric biomanufacturing facility opened (Ohio) Opened first fully electric Amgen biomanufacturing site in Ohio with on-site solar array sized to generate 2,038 MWh annually.
▾ expand
see 1 more event →